残余或复发性中枢神经细胞瘤的管理

The management of residual or recurrent central neurocytoma.

作者信息

Thawani Jayesh P, Lee John Y K

机构信息

Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, 3 Silverstein Building, 3400 Spruce Street, Philadelphia, PA 19104, USA.

Department of Neurosurgery, Pennsylvania Hospital, Perelman School of Medicine at the University of Pennsylvania, Washington Square West Building, 235 South 8th Street, Philadelphia, PA 19106, USA.

出版信息

Neurosurg Clin N Am. 2015 Jan;26(1):67-81. doi: 10.1016/j.nec.2014.09.002.

DOI:10.1016/j.nec.2014.09.002

PMID:25432185

Abstract

Treatment following neurosurgical resection or biopsy of a central neurocytoma depends on the pathologic analysis and proliferative activity demonstrated, the extent of surgical resection, the neuroanatomic location and accessibility of residual tumor, and the patient's postoperative condition. The risks and benefits of additional surgery, radiation therapy, and/or chemotherapy should be weighed and individualized based on these factors and guided by the existing literature.

摘要

中枢神经细胞瘤经神经外科手术切除或活检后的治疗取决于病理分析及所显示的增殖活性、手术切除范围、残余肿瘤的神经解剖位置及可及性，以及患者的术后状况。应基于这些因素权衡并个体化考虑额外手术、放射治疗和/或化疗的风险与益处，并以现有文献为指导。